Lunesta and Diplopia - a phase IV clinical study of FDA data

Summary:

Diplopia is reported as a side effect among people who take Lunesta (eszopiclone), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Lexapro, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Diplopia when taking Lunesta. It is created by eHealthMe based on reports of 25,141 people who have side effects when taking Lunesta from the FDA, and is updated regularly.

What is Lunesta?

Lunesta has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 26,936 Lunesta users. Check the latest studies of Lunesta.

What is Diplopia?

Diplopia (double vision) is found to be associated with 1,428 drugs and 1,895 conditions by eHealthMe. Check the latest studies of Diplopia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

25,141 people reported to have side effects when taking Lunesta.
Among them, 53 people (0.21%) have Diplopia.

Among these 53 people:

How long have people been on Lunesta when they have Diplopia? *

What is the gender of people who have Diplopia when taking Lunesta? *

female: 66.04 %
male: 33.96 %

What is the age of people who have Diplopia when taking Lunesta? *

What are other drugs people take besides Lunesta? *

What are other side effects people have besides Diplopia? *

Chest Pain: 29 people, 54.72%
Dyspnea (difficult or laboured breathing): 28 people, 52.83%
Weakness: 27 people, 50.94%
Headache (pain in head): 24 people, 45.28%
Muscle Spasms (muscle contraction): 24 people, 45.28%
Back Pain: 23 people, 43.40%
Vision Blurred: 22 people, 41.51%
Dizziness: 21 people, 39.62%
Confusional State: 21 people, 39.62%
High Blood Cholesterol: 19 people, 35.85%

What are the existing conditions these people have? *

Stress And Anxiety: 14 people, 26.42%
Bipolar Disorder (mood disorder): 12 people, 22.64%
Headache (pain in head): 12 people, 22.64%
Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 9.43%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 7.55%
High Blood Cholesterol: 4 people, 7.55%
Asthma: 4 people, 7.55%
Back Pain: 4 people, 7.55%
Belching (release of gas from the digestive tract): 4 people, 7.55%
Gait Disturbance: 4 people, 7.55%

* Approximation only. Some reports may have incomplete information.

Do you take Lunesta and have Diplopia?

- Check whether Diplopia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lunesta:

Lunesta (26,936 reports)

Diplopia treatments and more:

Diplopia (32,466 reports)

Browse all side effects of Lunesta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diplopia:

Diplopia (1,428 drugs)

Browse all the conditions that are associated with Diplopia:

Diplopia (1,895 conditions)

Related publications that referenced our studies

Lai SW, Lai HC, Lin CL, Liao KF, "Zopiclone use associated with increased risk of acute pancreatitis: a case–control study in Taiwan", International journal of clinical practice, 2015 Nov .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Lai SW, Lai HC, Lin CL, Liao KF, "Zopiclone use associated with increased risk of acute pancreatitis: a case–control study in Taiwan", International journal of clinical practice, 2015 Nov .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on eszopiclone (the active ingredients of Lunesta) and Lunesta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.